Patents by Inventor Steven Griffiths
Steven Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180256824Abstract: An automatic injection device including a housing, a chamber with a first compartment and a second compartment, and a seal structure between the compartments. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, where the seal includes a plug and an outer sealing member. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment. The automatic injection device also includes a needle assembly and an activation assembly. Activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.Type: ApplicationFiled: November 27, 2017Publication date: September 13, 2018Inventors: Steven Griffiths, Robert L. Hill
-
Publication number: 20160250419Abstract: An automatic injection device including a housing, a chamber with a first compartment and a second compartment, and a seal structure between the compartments. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, where the seal includes a plug and an outer sealing member. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment. The automatic injection device also includes a needle assembly and an activation assembly. Activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.Type: ApplicationFiled: May 5, 2016Publication date: September 1, 2016Inventors: Steven Griffiths, Robert L. Hill
-
Publication number: 20150289006Abstract: A media recording device automatically records selected broadcast programmes according to categories specified by the user, without requiring the user to specify in advance which programmes are to be recorded. The recorded programmes are then presented to the user for selection, and the selected programmes may be played back immediately or saved for later playback. Each broadcast programme may be allocated a priority, and the device may decide which programmes to record or delete according to their relative priority. For each broadcast programme, a corresponding visibility period may be specified, during which the programme can be selected for playback and is not deleted. There may be a delay between the broadcast of the programme and the beginning of its visibility period. An expiry time may be specified for each programme, after which the programme is deleted. There may be a delay between the end of the visibility period and the expiry time.Type: ApplicationFiled: April 17, 2015Publication date: October 8, 2015Inventors: Michele Seisun, Herve Murret-Labarthe, Steven Griffith
-
Publication number: 20150283327Abstract: An automatic injection device including a housing, a chamber with a first compartment and a second compartment, and a seal structure between the compartments. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, where the seal includes a plug and an outer sealing member. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment. The automatic injection device also includes a needle assembly and an activation assembly. Activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.Type: ApplicationFiled: June 18, 2015Publication date: October 8, 2015Inventors: Steven Griffiths, Robert L. Hill
-
Patent number: 9025940Abstract: A media recording device automatically records selected broadcast programs according to categories specified by the user, without requiring the user to specify in advance which programs are to be recorded. The recorded programs are then presented to the user for selection, and the selected programs may be played back immediately or saved for later playback. Each broadcast program may be allocated a priority, and the device may decide which programs to record or delete according to their relative priority. For each broadcast program, a corresponding visibility period may be specified, during which the program can be selected for playback and is not deleted. There may be a delay between the broadcast of the program and the beginning of its visibility period. An expiry time may be specified for each program, after which the program is deleted. There may be a delay between the end of the visibility period and the expiry time.Type: GrantFiled: May 23, 2006Date of Patent: May 5, 2015Assignee: British Sky Broadcasting LimitedInventors: Michele Seisun, Herve Murret-Labarthe, Steven Griffith
-
Publication number: 20150018761Abstract: An automatic injection device including a housing, a chamber with a first compartment and a second compartment, and a seal structure between the compartments. The seal structure is initially in a sealing condition that seals the first compartment from the second compartment, where the seal includes a plug and an outer sealing member. The plug is slidably movable within the outer sealing member to convert the seal structure from the sealing condition to a mixing condition by opening a path between the first compartment and the second compartment. The automatic injection device also includes a needle assembly and an activation assembly. Activation of the activation assembly causes (1) pressurization of the first compartment, (2) the seal structure to convert from the sealing condition to the mixing condition, and (3) the first and second medicament components to be mixed and forced through the needle assembly.Type: ApplicationFiled: July 11, 2013Publication date: January 15, 2015Inventors: Steven Griffiths, Robert L. Hill
-
Publication number: 20120089997Abstract: An improved media system is provided for sharing, accessing and managing stored media content between a plurality of networked Set-Top Boxes (STB). Aspects include displaying a global STB planner listing media content stored on all remote STBs, switching between remote STB planners and filtering remote listings of media content.Type: ApplicationFiled: January 25, 2010Publication date: April 12, 2012Applicant: BRITISH SKY BROADCASTING LIMITEDInventors: Dounia Safouane, John Dollin, Remi Brunier, Peter Sahota, Steven Griffith, Dominic Farrell, Adam Drewer
-
Publication number: 20120071630Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.Type: ApplicationFiled: August 12, 2011Publication date: March 22, 2012Applicants: OTTAWA HEALTH RESEARCH INSTITUTE, NOVARTIS AGInventors: STEVEN GRIFFITHS, RACHAEL JAME RITCHIE, JOEL HEPPELL
-
Patent number: 7998484Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.Type: GrantFiled: November 24, 2009Date of Patent: August 16, 2011Assignees: Novartis AG, Ottawa Health Research InstituteInventors: Steven Griffiths, Rachael Jane Ritchie, Joel Heppell
-
Publication number: 20110116761Abstract: A broadcast receiver (3) provides independent viewing of live or recorded programmes to primary and secondary locations (42a, 42b), which may share a common planner showing information on programmes selected for recording. The receiver (3) applies rules to govern the use of tuners to prevent conflicts between the two locations. Global settings may be altered only at the primary location (42a), while local settings may be applied independently at either location. Pay per view and day pass functions may be shared between locations.Type: ApplicationFiled: June 16, 2008Publication date: May 19, 2011Inventors: Nicholas James, Nigel David Bodkin, Steven Griffith, Xavier Willame, Ellen Fiona Collins, Dounia Safouane
-
Publication number: 20100136038Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.Type: ApplicationFiled: November 24, 2009Publication date: June 3, 2010Inventors: Steven Griffiths, Rachael Jane Ritchie, Joel Heppell
-
Patent number: 7556614Abstract: A separation assembly for initially keeping a first component separate from a second component includes a generally cylindrical body slidably supported within a container between the first and second components. The body includes a seal structure having an inner seal member that initially seals the first component from the second component. In response to a predetermined operating condition, the inner seal member allows the first component to flow through at least one flow path in the seal structure to mix with the second component. The body further includes a flow distributing member disposed adjacent the seal structure to evenly distribute the first component into the second component. The seal structure and the flow distributing member form a single unit.Type: GrantFiled: September 3, 2003Date of Patent: July 7, 2009Assignee: Meridian Medical Technologies, Inc.Inventors: Steven Griffiths, Robert L. Hill, John G. Wilmot
-
Publication number: 20090087167Abstract: A media recording device automatically records selected broadcast programmes according to categories specified by the user, without requiring the user to specify in advance which programmes are to be recorded. The recorded programmes are then presented to the user for selection, and the selected programmes may be played back immediately or saved for later playback. Each broadcast programme may be allocated a priority, and the device may decide which programmes to record or delete according to their relative priority. For each broadcast programme, a corresponding visibility period may be specified, during which the programme can be selected for playback and is not deleted. There may be a delay between the broadcast of the programme and the beginning of its visibility period. An expiry time may be specified for each programme, after which the programme is deleted. There may be a delay between the end of the visibility period and the expiry time.Type: ApplicationFiled: May 23, 2006Publication date: April 2, 2009Applicant: British Sky Broadcasting LimitedInventors: Michele Seisun, Herve Murret-Labarthe, Steven Griffith
-
Publication number: 20080077083Abstract: An automatic injector separately stores liquid and dry components in respective compartments. When the injector is activated, a fluid-directing member between the liquid and dry compartments causes the liquid component to form a vortex as the liquid flows into the dry compartment. This allows the two components to combine more thoroughly and quickly to form a liquid solution that is delivered to an injection site.Type: ApplicationFiled: August 29, 2007Publication date: March 27, 2008Inventors: Steven Griffiths, Robert Hill, Matthew Robben
-
Publication number: 20070142769Abstract: An automatic medicament injector having a compartment for a dry medicament component and a compartment for a wet medicament component. The two compartments are separated by a seal structure that converts from a sealing condition to a mixing condition when the device is activated. The seal structure includes a wiper that scrapes the interior walls in the dry component compartment to prevent the dry component from accumulating at the seal/glass interface. A tapered insert funnels the mixed medicament components to an attached needle assembly, but can be removed when the device is filled. A filter is provided between the medicament compartments and the needle assembly. A chamber between the filter and the needle allows for better flow through the filter. An actuation assembly drives the seal structure into the mixing condition and forces the mixed medicament through the needle and into the user.Type: ApplicationFiled: January 26, 2007Publication date: June 21, 2007Inventors: Steven Griffiths, Robert Hill
-
Publication number: 20070142768Abstract: An automatic medicament injector having a compartment for a dry medicament component and a compartment for a wet medicament component. The two compartments are separated by a seal structure that converts from a sealing condition into a mixing condition when the device is activated. The seal structure includes a wiper that scrapes the interior walls in the dry component compartment to prevent the dry component from accumulating at the seal/glass interface. A tapered insert funnels the mixed medicament components to an attached needle assembly, but can be removed when the device is filled. A filter is provided between the medicament compartments and the needle assembly. A chamber between the filter and the needle allows for better flow through the filter. An actuation assembly drives the seal structure into the mixing condition and forces the mixed medicament through the needle and into the user.Type: ApplicationFiled: January 26, 2007Publication date: June 21, 2007Inventors: Steven Griffiths, Robert Hill
-
Publication number: 20070123818Abstract: An automatic medicament injector having a compartment for a dry medicament component and a compartment for a wet medicament component. The two compartments are separated by a seal structure that converts from a sealing condition to a mixing condition when the device is activated. The seal structure includes a wiper that scrapes the interior walls in the dry component compartment to prevent the dry component from accumulating at the seal/glass interface. A tapered insert funnels the mixed medicament components to an attached needle assembly, but can be removed when the device is filled. A filter is provided between the medicament compartments and the needle assembly. A chamber between the filter and the needle allows for better flow through the filter. An actuation assembly drives the seal structure into the mixing condition and forces the mixed medicament through the needle and into the user.Type: ApplicationFiled: January 26, 2007Publication date: May 31, 2007Inventors: Steven Griffiths, Robert Hill
-
Publication number: 20070055236Abstract: The present invention is an apparatus and method for stabilizing the facet joints of the spine. One aspect of the present invention is the stabilization of the facet joint by insertion of a facet implant through two opposing facet surfaces. The facet joint is not fixedly frozen by insertion of the screw, but instead the facet surfaces are flexibly and movably anchored to preserve movement because the screw or anchor includes a flexible intermediate portion which is positioned between the facet surfaces. The facet implant may be in the form of a screw or other anchor with the intermediate portion in the form of a polyaxial head, a cord, a spring, etc. The facet implant may furthermore be used in conjunction with a facet spacer that is placed between the first and second facet.Type: ApplicationFiled: September 2, 2005Publication date: March 8, 2007Applicant: Zimmer Spine, Inc.Inventors: Robert Hudgins, Steven Griffith, Adam Shinbrot
-
Publication number: 20070041988Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.Type: ApplicationFiled: September 22, 2006Publication date: February 22, 2007Inventors: Steven Griffiths, Rachael Ritchie, Joel Heppell
-
Patent number: 7128917Abstract: The present invention provides the use of nucleic acid sequences and/or amino acid sequences in the preparation of a vaccine for the protection of fish against infectious salmon anaemia virus. Specifically, such vaccines contain at least one nucleic acid sequence which is derived from ISAV or synthetically prepared analogues thereof, or substantially homologous sequences. These nucleic acid sequences are transcripted and translated into peptide sequences which are incorporated into a vaccination strategy to induce and immune response to the surface antigens of ISAV and therefore ISAV itself. Therefore both the use of a vaccine against ISAV, and the incorporation of peptide sequences is herein described.Type: GrantFiled: April 2, 2004Date of Patent: October 31, 2006Assignees: Novartis, AG, Ottawa Health Research InstituteInventors: Steven Griffiths, Rachael Jane Ritchie, Joel Heppell